Tumor necrosis factor-alpha in heart failure: More questions than answers

被引:8
作者
Charakida, M [1 ]
Halcox, JPJ [1 ]
机构
[1] UCL, Inst Child Hlth, Dept Cardiol, Vasc Physiol Unit, London WC1N 1EH, England
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2005年 / 58卷 / 05期
关键词
D O I
10.1157/13074839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:470 / 472
页数:3
相关论文
共 19 条
[1]   Serum from patients with severe heart failure downregulates eNOS and is proapoptotic -: Role of tumor necrosis factor-α [J].
Agnoletti, L ;
Curello, S ;
Bachetti, T ;
Malacarne, F ;
Gaia, G ;
Comini, L ;
Volterrani, M ;
Bonetti, P ;
Parrinello, G ;
Cadei, M ;
Grigolato, PG ;
Ferrari, R .
CIRCULATION, 1999, 100 (19) :1983-1991
[2]   C-reactive protein as a predictor of improvement and readmission in heart failure [J].
Alonso-Martínez, JL ;
Llorente-Diez, B ;
Echegaray-Agara, M ;
Olaz-Preciado, F ;
Urbieta-Echezarreta, M ;
González-Arencibia, C .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :331-336
[3]   Inflammatory mediators in chronic heart failure: An overview [J].
Anker, SD ;
von Haehling, S .
HEART, 2004, 90 (04) :464-470
[4]   How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH [J].
Anker, SD ;
Coats, AJS .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 86 (2-3) :123-130
[5]   Cytokines as emerging targets in the treatment of heart failure [J].
Baumgarten, G ;
Knuefermann, P ;
Mann, DL .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (05) :216-223
[6]   Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats [J].
Bozkurt, B ;
Kribbs, SB ;
Clubb, FJ ;
Michael, LH ;
Didenko, VV ;
Hornsby, PJ ;
Seta, Y ;
Oral, H ;
Spinale, FG ;
Mann, DL .
CIRCULATION, 1998, 97 (14) :1382-1391
[7]   Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial [J].
Chung, ES ;
Packer, M ;
Lo, KH ;
Fasanmade, AA ;
Willerson, JT .
CIRCULATION, 2003, 107 (25) :3133-3140
[8]   TRANSCRIPTIONAL REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES - NF-KAPPA-B AND CYTOKINE-INDUCIBLE ENHANCERS [J].
COLLINS, T ;
READ, MA ;
NEISH, AS ;
WHITLEY, MZ ;
THANOS, D ;
MANIATIS, T .
FASEB JOURNAL, 1995, 9 (10) :899-909
[9]   Endothelium as a therapeutic target in heart failure [J].
Drexler, H .
CIRCULATION, 1998, 98 (24) :2652-2655
[10]   Impaired endothelium-mediated vasodilation in heart failure: Clinical evidence and the potential for therapy [J].
Elkayam, U ;
Khan, S ;
Mehboob, A ;
Ahsan, N .
JOURNAL OF CARDIAC FAILURE, 2002, 8 (01) :15-20